Clinical Trial Update: Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating triple antiplatelet therapy for reducing dependency after ischemic stroke was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Triple antiplatelet therapy for ischemic stroke

Snippet

Sponsor: University of Nottingham | Conditions: Stroke | Phase 3 | Status: TERMINATED